Глава 9

   1. Dolbeault, S., “Quantit? de survie versus qualit? de vie: quel impact des interventions psychoth?rapeutiques en oncologie? Le point en 2008,” Revue de presse d’oncologie clinique 17, no. 3 (2008).

   2. Lerner, M., Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer (Boston: MIT Press, 1994).

   3. Simonton, C. O., S. Matthews-Simonton, and J. Creighton, Gu?rir Envers et Contre Tout (Paris: Descl?e de Brouwer, 1990).

   4. Baghurst, K. I., P. A. Baghurst, and S. J. Record, “Public Perceptions of the Role of Dietary and Other Environmental Factors in Cancer Causation or Prevention,” Journal of Epidemiology and Community Health 46 (1992): 120-26.

   5. Antoni, M. H., S. K. Lutgendorf, S. W. Cole, et al., “The Influence of Bio-Behavioural Factors on Tumour Biology: Pathways and Mechanisms,” Nature Reviews Cancer 6, no. 3 (2006): 240-48.

   6. Temoshok, L., “Biopsychosocial Studies on Cutaneous Malignant Melanoma: Psychosocial Factors Associated with Prognostic Indicators, Progression, Psychophysiology and Tumor-Host Response,” Social Science & Medicine 20, no. 8 (1985): 833-40.

   7. Temoshok, L., “Personality, Coping Style, Emotion and Cancer: Towards an Integrative Model,” Cancer Surveys 6, no. 3 (1987): 545-67.

   8. Simonton, et al., Gu?rir Envers et Contre Tout.

   9. LeShan, L., Cancer as Turning Point (New York: Plume, 1990).

   10. Gawler, I., You Can Conquer Cancer—Prevention and Treatment (South Yarra, Australia: Michelle Anderson, 2001).

   11. Laplanche, J., and J. B. Pontalis, Vocabulaire de la Psychanalyse (Paris: Presses Universitaires de France, 1967).

   12. Pace, T. T., T. Mletzko, O. Alagbe, et al., “Increased Stress-Induced Inflammatory Responses in Male Patients with Major Depression and Increased Early Life Stress,” American Journal of Psychiatry 163, no. 9 (2006): 1630-33.

   13. Palesh, O., et al., “Stress History and Breast Cancer Recurrence,” Journal of Psychosomatic Research 63, no. 3 (2007): 233-39.

   14. Visintainer, M. A., J. R. Volpicelli, and M. E. P. Seligman. “Tumor Rejection in Rats After Inescapable or Escapable Shock,” Science 216 (1982): 437-39.

   15. Ben-Eliyahu, S., et al., “Stress Increases Metastatic Spread of a Mammary Tumor in Rats: Evidence for Mediation by the Immune System,” Brain, Behavior, & Immunity 5, no. 2 (1991): 193-205.

   16. Sapolsky, R. M., and T. M. Donnelly, “Vulnerability to Stress-Induced Tumor Growth Increases with Age in Rats: Role of Glucocorticoids,” Endocrinology 117, no. 2 (1985): 662-66.

   17. Thaker, P. H., et al., “Chronic Stress Promotes Tumor Growth and Angiogenesis in a Mouse Model of Ovarian Carcinoma,” Nature Medicine 12, no. 8 (2006): 939-44.

   18. Visintainer, et al., “Tumor Rejection in Rats . . .”

   19. Meares, A., “Regression of Osteogenic Sarcoma Metastases Associated with Intensive Meditation,” Medical Journal of Australia 2, no. 9 (1978): 433.

   20. Spiegel, D., and J. R. Bloom. “Group Therapy and Hypnosis Reduce Metastatic Breast Carcinoma Pain,” Psychosomatic Medicine 45, no. 4 (1983): 333-39.

   21. Spiegel, D., J. R. Bloom, and I. Yalom, “Group Support for Patients with Metastatic Cancer, a Randomized Outcome Study,” Archives of General Psychiatry 38, no. 5 (1981): 527-33.

   22. Spiegel, D., et al., “Effect of Psychosocial Treatment on Survival of Patients with Metastatic Breast Cancer,” Lancet 2, no. 8673 (Nov. 18, 1989): 1209-10.

   23. McCorkle, R., N. E. Strumpf, I. F. Nuamah, et al., “A Specialized Home Care Intervention Improves Survival Among Older Post-surgical Cancer Patients,” Journal of the American Geriatrics Society 48, no. 12 (2000): 1707-13.

   24. Kuchler, T., D. Henne-Bruns, S. Rappat, et al., “Impact of Psychotherapeutic Support on Gastrointestinal Cancer Patients Undergoing Surgery: Survival Results of a Trial,” Hepato-Gastroenterology 46, no. 25 (1999): 322-35.

   25. Richardson, J. L., D. R. Shelton, M. Krailo, et al., “The Effect of Compliance with Treatment on Survival Among Patients with Hematologic Malignancies,” Journal of Clinical Oncology 8, no. 2 (1990): 356-64.

   26. Fawzy, F. I., A. L. Canada, and N. W. Fawzy, “Malignant Melanoma: Effects of a Brief, Structured Psychiatric Intervention on Survival and Recurrence at 10-Year Follow-Up,” Archives of General Psychiatry 60, no. 1 (2003): 100-103.

   27. Linn, M. W., B. S. Linn, and R. Harris, “Effects of Counseling for Late Stage Cancer Patients,” Cancer 49, no. 5 (1982): 1048-55.

   28. Goodwin, P. J., M. Leszcz, M. Ennis, et al., “The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer,” New England Journal of Medicine 345, no. 24 (2001): 1719-26.

   29. Edelman, S., J. Lemon, D. R. Bell, et al., “Effects of Group CBT on the Survival Time of Patients with Metastatic Breast Cancer,” Psycho-Oncology 8, no. 6 (1999): 474-81.

   30. Ilnyckyj, A., J. Farber, M. Chang, et al., “A Randomized Controlled Trial of Psychotherapeutic Intervention in Cancer Patients,” Annals of the Royal College of Physicians and Surgeons of Canada 27 (1994): 93-96.

   31. Cunningham, A. J., C. V. Edmonds, G. P. Jenkins, et al., “A Randomized Controlled Trial of the Effects of Group Psychological Therapy on Survival in Women with Metastatic Breast Cancer,” Psycho-Oncology 7, no. 6 (1998): 508-17.

   32. Kissane, D. W., A. Love, A. Hatton, et al., “Effect of Cognitive-Existential Group Therapy on Survival in Early-Stage Breast Cancer,” Journal of Clinical Oncology 22, no. 21 (2004): 4255-60.

   33. Spiegel, D., et al., “Effects of Supportive-Expressive Group Therapy on Survival of Patients with Metastatic Breast Cancer: A Randomized Prospective Trial,” Cancer 110, no. 5 (2007): 1130-38.

   34. Everson, S. A., et al., “Hopelessness and Risk of Mortality and Incidence of Myocardial Infarction and Cancer,” Psychosomatic Medicine 58, no. 2 (1996): 113-121.

   35. Chida, Y., et al., “Do Stress-Related Psychosocial Factors Contribute to Cancer Incidence and Survival?” Nature Clinical Practice Oncology 5, no. 8 (2008). Doi: 10.1038/ncponc1134.

   36. Levy, S. M., R. B. Herberman, M. Lippman, et al., “Immunological and Psycho social Predictors of Disease Recurrence in Patients with Early-Stage Breast Cancer,” Behavioral Medicine 17, no. 2 (1991): 67-75.

   37. Levy, S. M., R. B. Herberman, A. M. Maluish, et al., “Prognostic Risk Assessment in Primary Breast Cancer by Behavioral and Immunological Parameters,” Health Psychology 4, no. 2 (1985): 99-113.

   38. Levy, S., R. Herberman, M. Lippman, et al., “Correlation of Stress Factors with Sustained Depression of Natural Killer Cell Activity and Predicted Prognosis in Patients with Breast Cancer,” Journal of Clinical Oncology 5, no. 3 (1987): 348-53.

   39. Lutgendorf, S. K., A. K. Sood, B. Anderson, et al., “Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer,” Journal of Clinical Oncology 23, no. 28 (2005): 7105-13.

   40. Servan-Schreiber, D., Healing Without Freud or Prozac—Stress, Anxiety and Depression Without Drugs or Talk Therapy (London: Pan MacMillan, 2004).

   41. Servan-Schreiber, D., The Instinct to Heal: Curing Depression, Anxiety and Stress Without Drugs and Without Talk Therapy (New York: Rodale, 2004).

   42. Kabat-Zinn, J., Coming to Our Senses (New York: Hyperion, 2005).

   43. Rinpoche, S., Le Livre Tib?tain de la Vie et de la Mort (Paris: Livre de Poche, 2005).

   44. Dekker, J., E. Schouten, P. Klootwijk, et al., “Heart Rate Variability from Short-Term Electrocardiographic Recordings Predicts Mortality from All Causes in Middle-Aged and Elderly Men: The Zutphen Study,” American Journal of Epidemiology 145, no. 10 (1997): 899-908.

   45. Tsuji, H., F. Venditti, E. Manders, et al., “Reduced Heart Rate Variability and Mortality Risk in an Elderly Cohort: The Framingham Heart Study,” Circulation 90, no. 2 (1994): 878-83.

   46. Bernardi, L., P. Sleight, G. Bandinelli, et al., “Effect of Rosary Prayer and Yoga Mantras on Autonomic Cardiovascular Rhythms: Comparative Study,” British Medical Journal 323 (2001): 1446-49.

   47. Thayer, J. F., and E. Sternberg, “Beyond Heart Rate Variability: Vagal Regulation of Allostatic Systems,” Annals of the New York Academy of Sciences 1008 (2006): 361-72.

   48. Umetani, K., D. Singer, R. McCraty, et al., “Twenty-four Hour Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender over Nine Decades,” Journal of the American College of Cardiology 31, no. 3 (1999): 593-601.

   49. Dekker, Schouten, Klootwijk, et al., “Heart Rate Variability from Short-Term Electrocardiographic Recordings . . .”

   50. Bernardi, Sleight, Bandinelli, et al., “Effect of Rosary Prayer and Yoga Mantras on Autonomic Cardiovascular Rhythms.”

   51. Lutz, A., L. Greischar, N. Rawlings, et al., “Long-term Meditators Self-Induce High-Amplitude Gamma Synchrony During Mental Practice,” Proceedings of the National Academy of Sciences USA 101 (2004): 16369-73.

   52. Davidson, R. J., J. Kabat-Zinn, J. Schumacher, et al., “Alterations in Brain and Immune Function Produced by Mindfulness Meditation,” Psychosomatic Medicine 65, no. 4 (2003): 564-70.

   53. Rosenkranz, M. A., D. C. Jackson, K. M. Dalton, et al., “Affective Style and in Vivo Immune Response: Neurobehavioral Mechanisms,” Proceedings of the National Academy of Sciences 100 (2003): 11148-52.

   54. Gruzelier, J., A. Burgess, T. Baldewig, et al., “Prospective Associations Between Lateralized Brain Function and Immunte Status in HIV Infection: Analysis of EEG, Cognition and Mood over 30 Months,” International Journal of Psychophysiology 23 (1996): 215-24.

   55. Kiecolt-Glaser, J. K., R. Glaser, D. Williger, et al., “Psychosocial Enhancement of Immunocompetence in a Geriatric Population,” Health Psychology 4, no. 1 (1985): 25-41.

   56. Creswell, J. D., Myers, H. F., Cole, S. W., Irwin, M. R., “Mindfulness Meditation Training Effects on CD4+T Lymphocytes in HIV-1 Infected Adults: A Small Randomized Controlled Trial,” Brain Behav Immun (2008).

   57. Gawler, You Can Conquer Cancer.

   58. Lillberg, K., P. K. Verkasalo, J. Kaprio, et al., “Stressful Life Events and Risk of Breast Cancer in 10,808 Women: A Cohort Study,” American Journal of Epidemiology 157 (2003): 415-23.

   59. Price, M. A., C. C. Tennant, P. N. Butow, et al., “The Role of Psychosocial Factors in the Development of Breast Carcinoma: Part II: Life Event Stressors, Social Support, Defense Style, and Emotional Control and Their Interactions,” Cancer 91, no. 4 (2001): 686-97.

   60. Bartrop, R. W., E. Luckhurst, L. Lazarus, et al., “Depressed Lymphocyte Function After Bereavement,” Lancet 1, no. 8016 (1977): 834-36.

   61. Ironson, G., C. Wynings, N. Schneiderman, et al., “Posttraumatic Stress Symptoms, Intrusive Thoughts, Loss, and Immune Function After Hurricane Andrew,” Psychosomatic Medicine 59, no. 2 (1997): 128-41.

   62. Irwin, M., M. Daniels, S. C. Risch, et al., “Plasma Cortisol and Natural Killer Cell Activity During Bereavement,” Biological Psychiatry 24, no. 2 (1988): 173-78.

   63. Weisberg, R. B., S. E. Bruce, J. T. Machan, et al., “Nonpsychiatric Illness Among Primary Care Patients with Trauma Histories and Posttraumatic Stress Disorder,” Psychiatric Services 53, no. 7 (2002): 848-54.

   64. Dong, M., W. H. Giles, V. J. Felitti, et al., “Insights into Causal Pathways for Ischemic Heart Disease: Adverse Childhood Experiences Study,” Circulation 110, no. 13 (2004): 1761-66.

   65. Dew, M., R. Kormos, L. Roth, et al., “Early Post-Transplant Medical Compliance and Mental Health Predict Physical Morbidity and Mortality 1-3 Years After Heart Transplantation,” Journal of Heart and Lung Transplantation 18 (1999): 549-62.

   66. Felitti, V., R. Anda, D. Nordenberg, et al., “Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Dealth in Adults,” American Journal of Preventive Medicine 14 (1998): 245-58.

   67. American Psychiatric Association, Guidelines for the Psychiatric Treatment of Acute Stress Disorder and Posttraumatic Stress Disorder (Washington: American Psychiatric Association, 2004).

   68. Bradley, R., J. Greene, E. Russ, et al., “A Multidimensional Meta-Analysis of Psychotherapy for PTSD,” American Journal of Psychiatry 162 (2005): 214-27.

   69. Bisson, J. I., A. Ehlers, R. Matthews, et al., “Psychological Treatments for Chronic Post-Traumatic Stress Disorder: Systematic Review and Meta-Analysis,” British Journal of Psychiatry 190 (2007): 97-104.

   70. Antoni, Lutgendorf, Cole, et al., “The Influence of Bio-Behavioral Factors on Tumour Biology.”

   71. Reiche, E. M. V., S. O. V. Nunes, and H. K. Morimoto, “Stress, Depression, the Immune System, and Cancer,” Lancet Oncology 5, no. 10 (2004): 617-25.

   72. Petrie, K., R. Booth, J. Pennebaker, et al., “Disclosure of Trauma and Immune Response to Hepatitis B Vaccination Program,” Journal of Consulting & Clinical Psychology 63 (1995): 787-92.

   73. Zaslow, J., The Girls from Ames: A Story of Women and Friendship (New York: Penguin Group, 2009).

   74. Parker-Pope, T., “What Are Friends For? A Longer Life,” New York Times, April 21, 2009.

   75. Kroenke, C. H., et al., “Social Networks, Social Support, and Survival After Breast Cancer Diagnosis,” Journal of Clinical Oncology 24, no. 7 (2006): 1105-11.

   76. Orth-Gomer, K., A. Rosengren, and L. Wilhelmsen, “Lack of Social Support and Incidence of Coronary Heart Disease in Middle-Aged Swedish Men,” Psychosomatic Medicine 55, no. 1 (1993): 37-43.

   77. Lerner, Choices in Healing.

   78. Solomon, S., E. T. Gerrity, and A. M. Muff, “Efficacy of Treatments for Posttraumatic Stress Disorder,” JAMA 268 (1992): 633-38.

   79. Brady, K., T. Pearlstein, G. Asnis, et al., “Efficacy and Safety of Sertraline Treatment of Posttraumatic Stress Disorder,” JAMA 283 (2000): 1837-44.

   80. Davidson, J. R. T., B. O. Rothbaum, B. Van Der Kolk, et al., “Multicenter, Double-Blind Comparison of Sertraline and Placebo in the Treatment of Posttraumatic Stress Disorder,” Archives of General Psychiatry 58 (2001): 485-92.

   81. Asnis, G. M., S. R. Kohn, M. Henderson, et al., “SSRIs Versus Non-SSRIs in Post-Traumatic Stress Disorder: An Update with Recommendations,” Drugs 64, no. 4 (2004): 383-404.

   82. van Etten, M.L. and S. Taylor, “Comparative Efficacy of Treatments for Post Traumatic Stress Disorder: A Meta-Analysis,” Clinical Psychology & Psychotherapy 5 (1998): 126-144.

   83. Maxfield, L., and L. A. Hyer, “The Relationship Between Efficacy and Methodology in Studies Investigating EMDR Treatment of PTSD,” Journal of Clinical Psychology 58 (2002): 23-41.

   84. Sack, M., W. Lempa, and F. Lamprecht, “Study Quality and Effect Sizes—a Meta-Analysis of EMDR Treatment for Posttraumatic Stress Disorder,” Psychother apie, Psychosomatik, Medizinische Psychologie 51, no. 9-10 (2001): 350-355.

   85. Expertise Collective INSERM, et al., Psychoth?rapie: Trois approches ?valu?es, eds., INSERM Unit? d’Evaluation et d’Expertise Collective, et al., Paris: 2004, Institut National de la Sant? et de la Recherche M?dicale France, 2004.

   86. Shapiro, F., Eye-Movement Desensitization and Reprocessing: Basic Principles, Protocols and Procedures (New York: Guilford, 2001).

   87. K?bler-Ross, E., On Death and Dying (New York: Touchstone, 1969).

   88. Bisson, J. and M. Andrew, “Psychological Treatment of Post-Traumatic Stress Disorder (PTSD) (Review),” Cochrane Database of Systematic Reviews, no. 3 (2007): CD004046.

   89. Shapiro, F., Manuel d’EMDR (Int?gration neuro-?motionnelle par les mouve ments oculaires)—principes, protocoles, proc?dures (Paris: Dunod, 2007).

   90. Stickgold, R., “EMDR: A Putative Neurobiological Mechanism,” Journal of Clinical Psychology 58 (2002): 61-75.

   91. Anderson, B. L., et al., “Psychological, Behavioral, and Immune Changes After a Psychological Intervention: A Clinical Trial,” Journal of Clinical Oncology 22, no. 17 (2004): 3570-80.

   92. Anderson, B. L., et al., “Distress Reduction from a Psychological Intervention Contributes to Improved Health for Cancer Patients,” Brain, Behavior, & Immunity 21, no. 7 (2007): 953-61.

   93. Thornton, L. M., et al., “Individual Trajectories in Stress Covary with Immunity During Recovery from Cancer Diagnosis and Treatments,” Brain, Behavior, & Immunity 21, no. 2 (2007): 185-94.